Editor’s corner: The top 10 Fierce Medtech of 2021 tracked COVID testing evolution

As we start to close out our second year of the COVID-19 pandemic, it’s admittedly difficult to muster the feelings of hope and possibility that traditionally come with the season. After 2021’s vaccine gains and declining case numbers were rebuffed by delta—and now by omicron—we might…